Cancer chemo immunotherapy - exploiting the immunogenic potential of cytotoxic chemotherapy

被引：0
|
作者：
Aston, W. J. [1 ,2 ]
Rinaldi, C. [1 ,2 ]
Fisher, S. A. [1 ,2 ]
Nowak, A. K. [1 ,2 ,3 ]
Lake, R. A. [1 ,2 ]
Lesterhuis, W. J. [1 ,2 ]
机构：
[1] Natl Ctr Asbestos Related Dis, Perth, WA, Australia
[2] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia
[3] Sir Charles Gairdner Hosp, Med Oncol, Perth, WA, Australia
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
250
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
  • [31] Exploiting temporal aspects of cancer immunotherapy
    Zemek, Rachael M.
    Anagnostou, Valsamo
    Pires da Silva, Ines
    Long, Georgina V.
    Lesterhuis, Willem Joost
    NATURE REVIEWS CANCER, 2024, 24 (07) : 480 - 497
  • [32] β Hydroxy β Methylbutyrate synergizes with cytotoxic chemotherapy and immunotherapy in a mouse model of pancreatic cancer.
    Coleman, Michael F.
    Liu, Kristyn A.
    Etigunta, Suhas K.
    Pfeil, Alex J.
    Tang, Xiaohu
    Fabela, Salvador
    Lashinger, Laura M.
    Cui, Zhengrong
    Hursting, Stephen D.
    CANCER RESEARCH, 2021, 81 (13)
  • [33] Exploiting innate immunity for cancer immunotherapy
    Ming Yi
    Tianye Li
    Mengke Niu
    Qi Mei
    Bin Zhao
    Qian Chu
    Zhijun Dai
    Kongming Wu
    Molecular Cancer, 22
  • [34] CHEMOTHERAPY COMBINATION AND CHEMO-IMMUNOTHERAPY IN ADVANCED GASTROINTESTINAL TUMORS
    BELPOMME, D
    BOHU, A
    MUSSET, M
    MATHE, G
    DIGESTION, 1977, 16 (03) : 230 - 230
  • [35] The immune modifying effects of chemotherapy and advances in chemo-immunotherapy
    Principe, Daniel R.
    Kamath, Suneel D.
    Korc, Murray
    Munshi, Hidayatullah G.
    PHARMACOLOGY & THERAPEUTICS, 2022, 236
  • [36] ADJUVANT CHEMOTHERAPY AND CHEMO-IMMUNOTHERAPY FOR GASTRIC-CARCINOMA
    LISE, M
    NITTI, D
    MARCHET, A
    KALAMIAN, H
    FORNASIERO, A
    FIORENTINO, M
    FARINATI, F
    DIMARIO, F
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1989, 21 (03): : 164 - 171
  • [37] Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
    Ioannis Alagkiozidis
    Andrea Facciabene
    Marinos Tsiatas
    Carmine Carpenito
    Fabian Benencia
    Sarah Adams
    Zdenka Jonak
    Carl H June
    Daniel J Powell
    George Coukos
    Journal of Translational Medicine, 9
  • [38] Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice
    Egli, Jerome
    Heiler, Stefan
    Weber, Felix
    Steiner, Guido
    Schwandt, Timo
    Bray-French, Katharine
    Klein, Christian
    Fenn, Sebastian
    Lotz, Gregor P.
    Opolka-Hoffmann, Eugenia
    Kraft, Thomas E.
    Petersen, Laetitia
    Moser, Rebecca
    DeGeer, Jonathan
    Siegel, Michel
    Finke, Daniela
    Bessa, Juliana
    Iglesias, Antonio
    MABS, 2022, 14 (01)
  • [39] CHEMOTHERAPY VERSUS CHEMO-IMMUNOTHERAPY WITH LEVAMISOLE OR CORYNEBACTERIUM-PARVUM IN ADVANCED LUNG-CANCER
    CHAHINIAN, AP
    GOLDBERG, J
    HOLLAND, JF
    REISMAN, A
    JAFFREY, IS
    MANDEL, EM
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1291 - 1297
  • [40] Generation of cytotoxic T cells against immunogenic peptides from heat shock proteins: Implications for immunotherapy of cancer.
    Witzens, M
    Trojan, A
    Harig, S
    Gribben, JG
    BLOOD, 1999, 94 (10) : 438A - 438A
12345